What You Should Know:
- Cellbyte, the AI-native platform that helps pharmaceutical companies accelerate drug launches, announces that it has raised $2.75 million in seed funding.
- The round was led by Frontline Ventures, with participation from Y Combinator, Pace Ventures, Saras Capital and Springboard Health Angels.
Cellbyte: Rebuilding Global Drug Launch Workflows for the AI Era
Cellbyte is an AI-native platform transforming how pharmaceutical companies prepare, price, and launch
Read More
Startups| Digital Health | | Health IT News, Analysis, Insights - HIT Consultant
FamilyWell Health Secures $8M to Expand Women’s Mental Health and Menopause Care Nationwide
What You Should Know:
- FamilyWell Health, an integrated women’s mental health company, raises $8M in Series A funding led by New Markets Venture Partners with participation from existing and new investors– .406 Ventures, GreyMatter Capital, The Alix Foundation, The Donna Fund, and The Lee Foundation.
- The investment will accelerate the company's national expansion of its maternal mental health model and extend integrated services into perimenopause and menopause
Read More
voize Nabs $50M to Scale AI Nursing Companion to U.S. and Europe
What You Should Know:
- voize, the AI company redefining nursing care, has secured $50M in Series A funding led by Balderton Capital.
- The investment will fuel its expansion into the U.S. and Europe, accelerating its mission to give nurses up to 30% of their time back from administrative work.
The Crisis Point: Administrative Burden and Nursing Shortage
Healthcare systems across the globe are facing a staffing crisis. The World Health Organization (WHO) predicts a global deficit of
Read More
No Barrier Raises $2.7M to Scale AI-Powered Medical Translation and Access
What You Should Know:
- No Barrier, the leader in AI-powered medical translation redefining language access in healthcare, today announced an oversubscribed $2.7 million Seed Round led by A-Squared Ventures, Esplanade Ventures, Rock Health Capital and Fusion.
- No Barrier’s AI-powered real time language interpretation technology integrates into existing clinician workflows, improving providers’ and health systems’ limited-English-proficiency (LEP) services to the highest quality with
Read More
Joy Secures $14M to Redefine the Parenting Experience
What You Should Know:
- Joy, a platform revolutionizing the parenting experience secures $14M in Series A funding co-led by Forerunner and Raga Partners, with participation from Magnify Ventures, Ingeborg Investments, Shazi Visram, Rogue Venture Partners, and Next Legacy Partners.
- The funding will be used to accelerate the development of the company’s advanced AI parenting platform, expand integrations with leading parenting brands, grow its expert network, and extend its services across
Read More
Evidium Raises $22M to Scale Computational Medical Knowledge
What You Should Know:
- Evidium, an innovative healthcare artificial intelligence company, has announced the close of its Series A equity funding round co-led by Health2047, the venture studio of the American Medical Association (AMA), and WGG Partners with additional participation from Interwoven Ventures and Mindset Ventures.
- The investment will be used to accelerate product development, expand the company's clinical modeling capabilities, and scale its go-to-market operations to
Read More
Hepta Emerges from Stealth with $6.7M to Pioneer AI-Driven Chronic Disease Liquid Biopsy
What You Should Know:
- Hepta, a biotechnology company focused on diagnosing chronic disease, has emerged from stealth announcing $6.7M in seed funding co-led by Felicis Ventures and Illumina Ventures, with participation from SeaX Ventures, Alumni Ventures, and AME Cloud Ventures.
- The company's core technology utilizes transformer-based AI to read the cell-free DNA (cfDNA) epigenome, enabling the detection of organ-specific signals for chronic conditions. Built by former leaders from
Read More
Onchilles Pharma Raises $25M to Advance N17350, Pioneering Next-Gen Cytotoxic Cancer Therapy
What You Should Know:
- Onchilles Pharma, a private biotech company pioneering next-generation cytotoxic therapeutics announced the publication of foundational preclinical data in the peer-reviewed journal Cell Reports Medicine, the close of a $25M Series A1 financing round.
- In addition, the company appointed Dr. Thomas A. Buchholz as a clinical advisor. The funding brings the total raised in Series A financing to $40M.
Foundational Preclinical Data Validates Cancer-Selective
Read More
Amae Health Secures $25M to Transform Severe Mental Illness Care with Integrated AI Platform
What You Should Know:
- Amae Health, a Public Benefit Corporation (PBC) and leader in outpatient treatment for Severe Mental Illness (SMI), announced the close of a $25M of pre-empted Series B financing led by Altos Ventures.
- The funding brings Amae’s total funding to more than $50M and will accelerate the company's mission to transform how conditions like schizophrenia, bipolar disorder, and treatment-resistant depression are understood and treated.
Achieving Significant and
Read More
Planbase Launches AI Workforce Management for Healthcare Platform with $2.1M
What You Should Know:
- Planbase, the first AI-native employee management platform designed specifically for healthcare, has officially launched, securing $2.1M in seed funding led by Y Combinator, LocalGlobe, and prominent angels.
- The company will use the funds to expand into more medium-large clinics nationwide and hire additional software engineers.
Automating Complex Workforce Management with AI
Managing employees in healthcare is uniquely complex, requiring prediction of
Read More
